| 中文名 | 葳岩仙皂苷 D |
|---|---|
| 英文名 | cauloside D |
| 中文别名 |
甲状腺霜D
红毛七皂苷D (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4AS,6AS,6BR,8,9R,10S,12,12BR,14BR)-9-(羟甲基)-2,2,6A,6B,9,12A-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H 葳岩仙皂苷 D,10 MM DMSO 溶液 (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8,9R,10S,12,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2 |
| 英文别名 |
[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexam
Olean-12-en-28-oic acid, 3-(α-L-abinopyranosyloxy)-23-hydroxy-, O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl ester, (3β,4α,18α) kizutasaponin K10 Cauloside D, 10 mM in DMSO Hederasaponin D (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (4aS,6aS,6bR,8,9R,10S,12,12bR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-cboxylate Hederoside G Pericpsaponin PJ3 inhibit,Inhibitor,Cauloside D 3β-(α-L-abinopyranosyloxy)-23-hydroxyolean-12-en-28-oic acid 6-O-[4-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]-β-D-glucopyranosyl ester |
| 描述 | Cauloside D 是从 Caulophyllum robustum Max 中分离出的一种三萜苷类化合物。Cauloside D 通过抑制 iNOS 和促炎细胞因子的表达发挥抗炎作用。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C53H86O22 |
|---|---|
| 分子量 | 1075.24000 |
| 精确质量 | 1074.56000 |
| PSA | 353.90000 |
| 上游产品 1 | |
|---|---|
| 下游产品 2 | |